Pfizer’s drug pricing deal with Trump ratchets up pressure on other pharma companies
Pfizer made headlines by forging a drug pricing agreement with the Trump administration, surprising many in the pharmaceutical industry. The move exposed rifts within Big Pharma, as other companies were left scrambling to respond.
5 days ago
1 min read
